Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
G288907-5mg | 5mg | In stock | $63.90 | |
G288907-10mg | 10mg | In stock | $98.90 | |
G288907-25mg | 25mg | In stock | $222.90 | |
G288907-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $414.90 | |
G288907-100mg | 100mg | In stock | $741.90 |
S1P1and S1P5agonist
Synonyms | GSK-2018682|1034688-30-6|GSK2018682|4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid|NJL503AIJA|4-[4-[5-(5-chloro-6-propan-2-yloxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid|1H-Indole-1-butanoic |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of S1P 1 receptor;Agonist of S1P 5 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-[4-[5-(5-chloro-6-propan-2-yloxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid |
---|---|
INCHI | InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29) |
InChi Key | NFIGDBFIDKDNIG-UHFFFAOYSA-N |
Canonical SMILES | CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl |
Isomeric SMILES | CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl |
PubChem CID | 24988201 |
Molecular Weight | 440.88 |
PubChem CID | 24988201 |
---|---|
CAS Registry No. | 1034688-30-6 |
ChEMBL Ligand | CHEMBL4297542 |
DrugBank Ligand | DB11987 |
GPCRdb Ligand | GSK2018682 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2206164 | Certificate of Analysis | Mar 14, 2022 | G288907 |
G2206173 | Certificate of Analysis | Mar 14, 2022 | G288907 |
G2206174 | Certificate of Analysis | Mar 14, 2022 | G288907 |
G2206175 | Certificate of Analysis | Mar 14, 2022 | G288907 |
G2206176 | Certificate of Analysis | Mar 14, 2022 | G288907 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 44.09, Max Conc. mM: 100 |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. |
1. Xu J, Gray F, Henderson A, Hicks K, Yang J, Thompson P, Oliver J. (2014) Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers.. Clin Pharmacol Drug Dev, 3 (3): (170-8). [PMID:27128606] |